Breastfeeding and transmission of HIV-1: Epidemiology and global magnitude

Advances in Experimental Medicine and Biology

Volumn 743, Issue , 2012, Pages 3-25

  Fowler, Mary Glenn ^a,b   Kourtis, Athena P ^c   Aizire, Jim ^b   Onyango Makumbi, Carolyne ^b   Bulterys, Marc ^d,e,f  

^a DEPARTMENT OF PATHOLOGY   (United States)

^b MAKERERE UNIVERSITY   (Uganda)

^c NATIONAL CENTER FOR CHRONIC DISEASE PREVENTION AND HEALTH PROMOTION   (United States)

^d CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^e CENTERS FOR DISEASE CONTROL AND PREVENTION   (United States)

^f UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABACAVIR; ANTIRETROVIRUS AGENT; DIDANOSINE; EFAVIRENZ; IMMUNOGLOBULIN A; IMMUNOGLOBULIN G; LAMIVUDINE; LOPINAVIR; NEVIRAPINE; PLACEBO; STAVUDINE; ZIDOVUDINE;

ARTICLE; BREAST FEEDING; CD4 LYMPHOCYTE COUNT; CHILD CARE; CHILD NUTRITION; DISEASE ASSOCIATION; DISEASE MARKER; GEOGRAPHIC DISTRIBUTION; HOST RESISTANCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; ILLNESS TRAJECTORY; IMMUNE RESPONSE; INFANT NUTRITION; INFECTION PREVENTION; INFECTION RATE; INFECTION RISK; INTESTINE MUCOSA; MATERNAL CARE; NUTRITIONAL DEFICIENCY; PRACTICE GUIDELINE; PREVALENCE; PRIMARY INFECTION; PRIORITY JOURNAL; PUERPERAL INFECTION; RISK FACTOR; TREATMENT INDICATION; TREND STUDY; VIRUS DETECTION; VIRUS LOAD; VIRUS TRANSMISSION;

HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 84859913830     PISSN: 00652598     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-4614-2251-8_1     Document Type: Article

References (110)

1. Cooper ER, Charurat M, Mofenson LM et al (2002) Combination antiretroviral strategies for the treatment of pregnant HIV-1-infected women and prevention of perinatal HIV-1 transmission. J Acquir Immune Defic Syndr Hum Retrovirol 29:484-94
2. Global report: UNAIDS report on the global AIDS epidemic 2010. http://www.unaids.org/documents/20101123-GlobalReport-em.pdf . Accessed Dec 2010
3. DeCock KM, Fowler MG, Mercier E et al (2000) Prevention of mother-to-child HIV-1 transmission in resourcepoor countries: translating research into policy and practice. JAMA 283:1175-1182
4. Townsend CL, Cortina-Borja M, Peckham CS et al (2008) Low rates of MTCT of HIV-1 following effective pregnancy interventions in the United Kingdom and Ireland, 2000-2006. AIDS 22:973-81
5. Zhou Z, Meyers K, Li X et al (2010) Prevention of mother-to-child transmission of HIV-1 using highly active antiretroviral therapy in rural Yunnan, China. J Acquir Immune Defic Syndr 53:S15-22
6. Mofenson LM (2010) Prevention in neglected subpopulations: prevention of mother-to-child transmission of HIV-1 infection. Clin Infect Dis 50:130-48
7. Bulterys M, Wilfert CM (2009) HAART during pregnancy and during breast feeding among HIV-1-infected women in the developing world: has the time come? AIDS 23:2473-7
8. Kourtis AP, Duerr A (2003) Prevention of perinatal HIV-1 transmission: a review of novel strategies. Expert Opin Investig Drugs 12:1-10
9. Kuhn L, Reitz C, Abrams EJ (2009) Breastfeeding and AIDS in the developing world. Curr Opin Pediatr 21:83-93
10. Newell ML (2006) Current issues in the prevention of mother to child transmission of HIV-1 infection. Trans R Soc Trop Med Hyg 100:1-5
11. Mmiro FA, Aizire J, Mwatha AK, Eshleman SH, Donnell D, Fowler MG et al (2009) Predictors of early and late mother-to-child transmission of HIV-1 in a breastfeeding population: HIV-1 network for prevention trials 012 experience, Kampala, Uganda. J Acquir Immune Defic Syndr 52:32-9
12. Nduati R, John G, Mbori-Ngacha D et al (2000) Effect of breastfeeding and formula feeding on transmission of HIV-1: a randomized clinical trial. JAMA 283:1167-1174
13. Jamieson DJ, Sibailly TS, Sadek R et al (2003) HIV-1 viral load and other risk factors for mother-to-child transmission of HIV-1 in a breast-feeding population in Côte dIvoire. J Acquir Immune Defic Syndr 34:430-436
14. Koulinska IN, Villamor E, Msamanga G et al (2006) Risk of HIV-1 transmission by breastfeeding among mothers infected with recombinant and non-recombinant HIV-1 genotypes. Virus Res 120:191-8
15. Rousseau CM, Nduati RW, Richardson BA et al (2003) Longitudinal analysis of human immunodeficiency virus type 1 RNA in breast milk and of its relationship to infant infection and maternal disease. J Infect Dis 187:741-7
16. Rousseau CM, Nduati RW, Richardson BA et al (2004) Association of levels of HIV-1 infected breast milk cells and risk of mother-to-child transmission. J Infect Dis 190:1880-8
17. The Breastfeeding and HIV International Transmission Study Group (2004) Late postnatal transmission of HIV-1 in breast-fed children: an individual patient data meta-analysis. J Infect Dis 189:2154-66
18. Bulterys M, Chao A, Dushimimana A, Saah A (1995) HIV-1 seroconversion after 20 months of age in a cohort of breastfed children born to HIV-1-infected women in Rwanda. AIDS 9:93-94
19. Dunn DT, Newell M-L, Ades AE, Peckham CS (1992) Risk of human immunodeficiency virus type 1 transmission through breastfeeding. Lancet 340:585-8
20. Van de Perre P, Simonon A, Msellati P, Hitimana DG, Vaira D, Bazubagira A et al (1991) Postnatal transmission of human immunodeficiency virus type 1 from mother to infant. A prospective cohort study in Kigali, Rwanda. N Engl J Med 325:593-8
21. Humphrey JH, Marinda E, Mutasa K, Moulton LH, Iliff PJ, Ntozini R et al (2010) Mother to child transmission of HIV-1 among Zimbabwean women who seroconverted postnatally: prospective cohort study. Br Med J 341:c6580
22. Liang K, Gui X-E, Zhang YZ, Zhuang K, Meyers K, Ho DD (2009) A case series of 104 women infected by HIV-1 via blood transfusion postnatally: high rate of HIV-1 transmission to infants through breastfeeding. J Infect Dis 200:682-6
23. Lewis P, Nduati R, Kreiss JK et al (1998) Cell-free human immunodeficiency virus type 1 in breast milk. J Infect Dis 177:34-9
24. Gray RR, Salemi M, Lowe A et al (2011) Multiple independent lineages of HIV-1 persist in breast milk and plasma. AIDS 25:143-152
25. Eshleman SH, Becker-Pergola G, Deseyve M et al (2001) Impact of human immunodeficiency virus type1 (HIV- 1) subtype on women receiving single-dose nevirapine prophylaxis to prevent HIV-1 vertical transmission (HIVNET 012 trial). J Infect Dis 184:914-917
26. Bjorndal A, Sonnerborg A, Tscherning C et al (1999) Phenotypic characteristics of human immunodeficiency virus type 1 subtype C isolates of Ethiopian AIDS patients. AIDS 15:647-53
27. Renjifo B, Gilbert P, Chaplin B et al (2004) Preferential in utero transmission of HIV-1 subtype C compared to subtype A or D. AIDS 18:1629-36
28. Koulinska IN, Villamor E, Chaplin B et al (2006) Transmission of cell-free and cell-associated HIV-1 through breast-feeding. J Acquir Immune Defic Syndr 41:93-9
29. Yang C, Li M, Newman RD et al (2003) Genetic diversity of HIV-1 in western Kenya: subtype-specific differences in mother-to-child transmission. AIDS 11:1667-74
30. Embree JE, Njenga S, Datta P et al (2000) Risk factors for postnatal mother-child transmission of HIV-1. AIDS 14:2535-41
31. Semba RD, Kumwenda N, Hoover DR et al (1999) Human immunodeficiency virus load in breast milk, mastitis, and mother-to-child transmission of human immunodeficiency virus type 1. J Infect Dis 180:93-8
32. Kumwenda N, Miotti PG, Taha TE et al (2002) Antenatal vitamin A supplementation increases birth weight and decreases anemia among infants born to human immunodeficiency virus-infected women in Malawi. Clin Infect Dis 35:618-24
33. Phiri W, Kasonka L, Collin S et al (2006) Factors influencing breast milk HIV-1 RNA viral load among Zambian women. AIDS Res Hum Retroviruses 22:607-14
34. Kupka R, Garland M, Msamanga G et al (2005) Selenium status, pregnancy outcomes, and mother-to-child transmission of HIV-1. J Acquir Immune Defic Syndr 29:201-10
35. Mehta S, Hunter DJ, Mugusi FM et al (2009) Perinatal outcomes, including mother-to-child transmission of HIV- 1, and child mortality and their association with maternal vitamin D status in Tanzania. J Infect Dis 200: 1022-30
36. Semba RD, Miotti P, Chiphangwi J et al (1994) Maternal vitamin A deficiency and mother-to-child transmission of HIV-1. Lancet 343:1593-7
37. Coutsoudis A, Pillay K, Spooner E et al (1999) Randomized trial testing the effect of vitamin A supplementation on pregnancy outcomes and early mother-to-child transmission in Durban, South Africa. AIDS 13:1517-24
38. Fawzi W, Msamanga G, Hunter D et al (2002) Randomized trial of vitamin supplements in relation to transmission of HIV-1 through breastfeeding and early child mortality. AIDS 16:1935-44
39. Kuhn L (2010) Milk mysteries: why are women who exclusively breastfeed less likely to transmit HIV-1 during breastfeeding? Clin Infect Dis 50:770-2
40. Requena M, Bouhlal H, Nasreddine N et al (2008) Inhibition of HIV-1 transmission in trans from dendritic cells to CD4+ by natural antibodies to the CRD domain of DC-SIGN purified from breast milk and intravenous immunoglobulins. Immunology 123:508-18
41. Kafulafula G, Hoover DR, Taha TE et al (2010) Frequency of gastroenteritis and gastroenteritis-associated mortality with early weaning in HIV-1-uninfected children born to HIV-1-infected women in Malawi. J Acquir Immune Defic Syndr 53:6-13
42. Kuhn L, Sinkala M, Semrau K et al (2010) Elevations in mortality associated with weaning persist into the second year of life among uninfected children born to HIV-1 infected mothers. Clin Infect Dis 50:437-44
43. Onyango-Makumbi C, Bagenda D, Mwatha A et al (2010) Early weaning of HIV-1 exposed uninfected infants and risk of serious gastroenteritis: findings from two perinatal HIV-1 prevention trials in Kampala, Uganda. J Acquir Immune Defic Syndr 53:20-7
44. Thea DM, Aldrovandi G, Kankasa C et al (2006) Post-weaning breast milk HIV-1 viral load, blood prolactin levels and breast milk volume. AIDS 20:1539-47
45. World Health Organization (2010) Antiretroviral drugs for treating pregnant women and preventing HIV-1 infection in infants: towards universal access. Recommendations for a public health approach (2010 version). http://www.who.int/HIV-1/pub/mtct/antiretroviral2010/en/index.html. Accessed Mar 2011
46. Winchester R, Pitt J, Charurat M et al (2004) Mother- to- child transmission of HIV-1 strong association with certain maternal HLA-B alleles independent of viral load implicates innate immune mechanism. J Acquir immune Defic Syndr 36:639-70
47. Mackelprang RD, John-Stewart G, Carrington M et al (2008) Maternal HLA homozygosity and mother-child HLA concordance increase the risk of vertical transmission of HIV-1. J Infect Dis 197:1156-1161
48. Belyakov IM, Berzofsky JA (2004) Immunobiology of mucosal HIV-1 infection and the basis for development of a new generation of mucosal AIDS vaccines. Immunity 20:247-53
49. Iliff PJ, Piwoz EG, Tavengwa NV et al (2005) Early exclusive breastfeeding reduces the risk of postnatal HIV-1 transmission and increases HIV-1-free survival. AIDS 19:699-708
50. Kourtis AP, Bulterys M, Nesheim S et al (2001) Understanding the timing of HIV-1 transmission from mother to infant. JAMA 285:709-12
51. Kourtis AP, Lee FK, Jamieson DJ et al (2006) Mother-to-child transmission of HIV-1: timing and implications for prevention. Lancet Infect Dis 6:726-32
52. Bryson YY, Luzuriaga K, Sullivan JL et al (1992) Proposed definitions for in utero versus intrapartum transmission of HIV-1. N Engl J Med 327:1246-7
53. John GC, Nduati R, Mbori-Ngacha DA et al (2001) Correlates of mother-to-child human immunodeficiency virus type 1 (HIV-1) transmission: association with maternal plasma HIV-1 RNA load, genital HIV-1 DNA shedding, and breast infections. J Infect Dis 183:206-212
54. Lohman-Payne B, Slyker J, Rowland-Jones SL (2010) Immune-based approaches to the prevention of mother-tochild transmission of HIV-1: active and passive immunization. Clin Perinat 37:787-805
55. Toniolo A, Serra C, Conaldi PG, Basolo F, Falcone V, Dolei A (1995) Productive HIV-1 infection of normal human mammary epithelial cells. AIDS 9:859-866
56. Dorosko SM, Connor RI. Primary human mammary epithelial cells endocytose HIV-1 and facilitate viral infection of CD4+ T lymphocytes. J Virol 84:10533-10542
57. Lyimo MA, Howell AL, Balandya E, Eszterhas SK, Connor RI (2009) Innate factors in human breast milk inhibit cell-free HIV-1 but not cell-associated HIV-1 infection of CD4+ cells. J Acquir Immune Defic Syndr 51:117-24
58. Bulek K, Swaidani S, Aronica M, Li X (2010) Epithelium: the interplay between innate and Th2 immunity. Immunol Cell Biol 88:257-68
59. Kalish LA, Pitt J, Lewis J et al (1997) Defining the time of fetal or perinatal acquisition of HIV-1 infection on the basis of age at first positive culture. J Infect Dis 175:712-5
60. Lunney KM, Iliff P, Mutasa K et al (2010) Associations between breast milk viral load, mastitis, exclusive breastfeeding, and postnatal transmission of HIV-1. Clin Infect Dis 50:762-769
61. Willumsen JF, Filteau SM, Coutsoudis A et al (2003) Breastmilk RNA viral load in HIV-1-infected South African women: effects of subclinical mastitis and infant feeding. AIDS 17:407-414
62. Hartmann SU, Berlin CM, Howett MK (2006) Alternative modified infant-feeding practices to prevent postnatal transmission of human immunodeficiency virus type 1 through breast milk: past, present, and future. J Hum Lact 22:75-88
63. Lehman DA, Farquhar C (2007) Biological mechanisms of vertical human immunodeficiency virus (HIV-1) transmission. Rev Med Virol 17:381-403
64. Giuliano M, Guidotti G, Andreotti M et al (2007) Triple antiretroviral prophylaxis administered during pregnancy and after delivery significantly reduces breast milk viral load: a study within the Drug Resource Enhancement Against AIDS and Malnutrition Program. J Acquir Immune Defic Syndr 44:286-291
65. Shapiro RL, Ndungu T, Lockman S, Shapiro RL et al (2005) Highly active antiretroviral therapy started during pregnancy or postpartum suppresses HIV-1 RNA, but not DNA, in breast milk. J Infect Dis 192:713-719
66. Farquhar C, VanCott TC, Mbori-Ngacha DA et al (2002) Salivary secretory leukocyte protease inhibitor is associated with reduced transmission of human immunodeficiency virus type 1 through breast milk. J Infect Dis 186:1173-1176
67. Baron S, Poast J, Richardson CJ et al (2000) Oral transmission of HIV-1 by infected seminal fluid and milk: a novel mechanism. J Infect Dis 181:498-504
68. Shugars DC (1999) Endogenous mucosal antiviral factors of the oral cavity. J Infect Dis 179:S431-5
69. Villamor E, Koulinska IN, Furtado J et al (2007) Long-chain n-6 polyunsaturated fatty acids in breast milk decrease the risk of HIV-1 transmission through breastfeeding. Am J Clin Nutr 86:682-9
70. Becquart P, Hocini H, Levy M, Sepou A, Kazatchkine MD, Belec L (2000) Secretory anti-human immunodeficiency virus (HIV-1) antibodies in colostrum and breast milk are not a major determinant of the protection of early postnatal transmission of HIV-1. J Infect Dis 181:532-539
71. Walter J, Kuhn L, Aldrovandi GM (2008) Advances in basic science understanding of mother-to-child HIV-1 transmission. Curr Opin HIV AIDS 3:146-150
72. Becquet R, Bland R, Leroy V et al (2009) Duration, pattern of breastfeeding and postnatal transmission of HIV-1: pooled analyses of individual data from West and South African cohorts. PLoS One 4:e7397
73. Coutsoudis A, Pillay K, Spooner E, Kuhn L, Coovadia HM (1999) Influence of infant-feeding patterns on early mother-to-child transmission of HIV-1 in Durban, South Africa: a prospective cohort study. South African Vitamin A Study Group. Lancet 354:471-476
74. Kuhn L, Sinkala M, Kankasa C et al (2007) High uptake of exclusive breastfeeding and reduced early post-natal HIV-1 transmission. PLoS One 2:e1363
75. Kourtis AP, Jamieson DJ, de Vincenzi I et al (2007) Prevention of human immunodeficiency virus-1 transmission to the infant through breastfeeding: new developments. Am J Obstet Gynecol 197:S113-S122
76. Gantt S, Shetty AK, Seidel KD et al (2007) Laboratory indicators of mastitis are not associated with elevated HIV-1 DNA loads or predictive of HIV-1 RNA loads in breast milk. J Infect Dis 196:570-576
77. Neville MO, Allen JC, Archer P et al (1991) Studies in human lactation: milk volume and nutrient composition during weaning and lactogenesis. Am J Clin Nutr 54:81-92
78. Lehman DA, Chung MH, John-Stewart GC et al (2008) HIV-1 persists in breast milk cells despite antiretroviral treatment to prevent mother-to-child transmission. AIDS 22:1475-1485
79. Connor EM, Sperling RS, Gelber R et al (1994) Reduction of maternal-infant transmission of human immunodeficiency virus type 1 with zidovudine treatment. Pediatric AIDS Clinical Trials Group Protocol 076 Study Group. N Engl J Med 331:1173-80
80. Shaffer N, Chuachoowong R, Mock PA et al (1999) Short-course zidovudine for perinatal HIV-1 transmission in Bangkok, Thailand: a randomised controlled trial. Bangkok Collaborative Perinatal HIV-1 Transmission Study Group. Lancet 353:773-80
81. Dabis F, Msellati P, Meda N et al (1999) 6-Month efficacy, tolerance, and acceptability of a short regimen of oral zidovudine to reduce vertical transmission of HIV-1 in breastfed children in Côte dIvoire and Burkina Faso: a double-blind placebo-controlled multicentre trial. DITRAME Study Group. Diminution de la Transmission Mère- Enfant. Lancet 353:786-92
82. Wiktor SZ, Ekpini E, Karon JM et al (1999) Short-course oral zidovudine for prevention of mother-to-child transmission of HIV-1 in Abidjan, Côte dIvoire: a randomized trial. Lancet 353:781-785
83. Leroy V, Karon J, Alioum A et al (2002) Twenty-four month efficacy of a maternal short-course zidovudine regimen to prevent mother-to-child transmission of HIV-1 in West Africa. AIDS 16:631-641
84. Guay LA, Musoke P, Fleming T et al (1999) Intrapartum and neonatal single dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: HIV-1NET 012 randomized trial. Lancet 354:795-802
85. Jackson JB, Musoke P, Fleming T et al (2003) Intrapartum and neonatal single-dose nevirapine compared with zidovudine for prevention of mother-to-child transmission of HIV-1 in Kampala, Uganda: 18-month follow-up of the HIVNET 012 randomised trial. Lancet 362:859-868
86. Marseille E, Kahn JG, Mmiro F et al (1999) Cost effectiveness of single-dose nevirapine regimen for mothers and babies to decrease vertical HIV-1 transmission in sub-Saharan Africa. Lancet 354:803-9
87. The Petra Study Team (2002) Efficacy of three short-course regimens of zidovudine and lamivudine in preventing early and late transmission of HIV-1 from mother to child in Tanzania, South Africa and Uganda [Petra Study]: a randomized, double blind, placebo-controlled trial. Lancet 359:1178-1186
88. Vyankandondera J, Lutchers S, Hassink E et al (2003) Reducing risk of HIV-1 transmission from mother to infant through breastfeeding using antiretroviral prophylaxis in infants (SIMBA). In: 2nd IAS conference on HIV-1 pathogenesis, treatment and prevention, Paris, France, 2003; Abstract LB07
89. Kilewo C, Karlsson K, Massawe A et al (2008) Prevention of mother-to-child transmission of HIV-1 through breast-feeding by treating infants prophylactically with lamivudine in Dar es Salaam, Tanzania: The Mitra Study. J Acquir Immune Defic Syndr 48:315-323
90. Six Week Extended-Dose Nevirapine (SWEN) Study Team (2008) Extended-dose nevirapine to 6 weeks of age for infants to prevent HIV-1 transmission via breastfeeding in Ethiopia, India, and Uganda: an analysis of three randomised controlled trials. Lancet 372:300-13
91. Kumwenda NI, Hoover DR, Mofenson LM et al (2008) Extended antiretroviral prophylaxis to reduce breast-milk HIV-1 transmission. N Engl J Med 359:119-29
92. Coovadia H, Brown E, Maldonado B et al (2011) HPTN 046: efficacy of extended daily infant nevirapine through age 6 months compared to 6 weeks for prevention of postnatal mother-to-child transmission (MTCT) of HIV-1 through breastfeeding (BF). In: 18th conference on retroviruses and opportunistic infections program abstract book, Boston, 2011; Abstract 123LB
93. Chasela CS, Hudgens MG, Jamieson DJ et al (2010) Maternal or infant antiretroviral drugs to reduce HIV-1 transmission. N Engl J Med 362:2271-81
94. Kilewo C, Karlsson K, Ngarina M et al (2009) Prevention of mother to child transmission of HIV-1 through breastfeeding by treating mothers with triple antiretroviral therapy in Dar es Salaam, Tanzania: the MITRA-PLUS study. J Acquir Immune Defic Syndr 52:406-16
95. Thomas T, Masaba R, Borkowf CG et al (2011) Triple antiretroviral prophylaxis to prevent mother-to-child HIV-1 transmission through breastfeeding-The Kisumu Breastfeeding Study, Kenya: a clinical trial. PLoS Med e1001015
96. Peltier CA, Ndayisaba GF, Lepage P et al (2009) Breastfeeding with maternal antiretroviral therapy or formula feeding to prevent HIV postnatal mother-to-child transmission in Rwanda. AIDS 23:2415-23
97. The Kesho Bora Study Group (2011) Triple antiretrovirals compared with zidovudine and single-dose nevirapine prophylaxis during pregnancy and breastfeeding for prevention of mother-to-child transmission of HIV-1 (Kesho Bora study): a randomised controlled trial. Lancet 3099(10):70288-7
98. The Kesho Bora Study Group (2010) Eighteen-month follow-up of HIV-1 infected mothers and their children enrolled in the Kesho Bora study observational cohorts. J Acquir Immune Defic Syndr 54:553-41
99. Shapiro RL, Hughes MD, Ogwu A et al (2010) Antiretroviral regimens in pregnancy and breastfeeding in Botswana. N Engl J Med 362:2282-94
100. Creek TL, Kim A, Lu L, Bowen A et al (2010) Hospitalization and mortality among primarily nonbreastfed children during a large outbreak of diarrhea and malnutrition in Botswana, 2006. J Acquir Immune Defic Syndr 53:14-9
101. Homsy J, Moore D, Barasa A et al (2010) Breastfeeding, mother-to-child HIV-1 transmission, and mortality among infants born to HIV-1-Infected women on highly active antiretroviral therapy in rural Uganda. J Acquir Immune Defic Syndr 53:28-35
102. Thomas T, Masaba R, van Eijk A et al (2007) Rates of diarrhea associated with early weaning among infants in Kisumu, Kenya [Abstract 774]. In: 14th conference on retroviruses and opportunistic infections, Los Angeles, CA, 2007
103. HIV-1 and infant feeding technical consultation held on behalf of the Inter-Agency Task Team (IATT) on prevention of HIV-1 infections in pregnant women, mothers and their infants. Consensus statement, Geneva, 25-27 October 2006
104. World Health Organization (2010) Guidelines on HIV-1 and infant feeding. Principles and recommendations for infant feeding in the context of HIV-1 and a summary of evidence. pp 1-49. http://whqlibdoc.who.int/publications/2010/ 9789241599535-eng.pdf. Accessed 16 Feb 2011
105. Stringer EM, Ekouevi DK, Coetzee D et al (2010) Coverage of nevirapine-based services to prevent mother-tochild HIV transmission in 4 African countries. JAMA 304:293-302
106. Kourtis AP, Bulterys M (2010) Mother-to-child transmission of HIV-1: pathogenesis, mechanisms and pathways. Clin Perinatol 37:721-38
107. Eslahpazir J, Jenabian MA, Bouhlal H et al (2008) Infection of macrophages and dendritic cells with primary R5-tropic HIV-1 type 1 inhibited by natural polyreactive anti-CCR5 antibodies purified from cervicovaginal secretions. Clin Vaccine Immunol 15:872-84
108. Ward S (2001) Natural anti-HIV-1 antibodies. Trends Immunol 22:544
109. de Perre V, Simonon A, Hitimana DG et al (1993) Infective and anti-infective properties of breast milk from HIV-1 infected women. Lancet 341:914-918
110. Farquhar C, Rowland-Jones S, Mbori-Ngacha D et al (2004) Human leukocyte antigen (HLA) B*18 and protection against mother-to-child HIV-1 type 1 transmission. AIDS Res Hum Retrovir 20:692-697